BMP Sunstone sees 33.4% rise in Q3 revenues
BMP Sunstone has posted a net loss of $1.26m for the third quarter 2010, or $0.03 loss per diluted share, compared to net loss of $208,000 or $0.01
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.